Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
Titel:
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
Auteur:
Atthobari, Jarir Asselbergs, Folkert W. Boersma, Cornelis de Vries, Robin Hillege, Hans L. van Gilst, Wiek H. Gansevoort, Ron T. de Jong, Paul E. de Jong-van den Berg, Lolkje T.W. Postma, Maarten J.